1. Home
  2. SCVL vs KROS Comparison

SCVL vs KROS Comparison

Compare SCVL & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shoe Carnival Inc.

SCVL

Shoe Carnival Inc.

HOLD

Current Price

$18.81

Market Cap

511.9M

ML Signal

HOLD

Logo Keros Therapeutics Inc.

KROS

Keros Therapeutics Inc.

HOLD

Current Price

$18.24

Market Cap

584.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCVL
KROS
Founded
1978
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
511.9M
584.9M
IPO Year
1993
2020

Fundamental Metrics

Financial Performance
Metric
SCVL
KROS
Price
$18.81
$18.24
Analyst Decision
Hold
Buy
Analyst Count
1
9
Target Price
N/A
$23.00
AVG Volume (30 Days)
496.6K
360.2K
Earning Date
03-19-2026
02-25-2026
Dividend Yield
3.12%
N/A
EPS Growth
N/A
N/A
EPS
2.10
1.57
Revenue
$1,144,197,000.00
$246,718,000.00
Revenue This Year
N/A
$6,924.79
Revenue Next Year
N/A
N/A
P/E Ratio
$9.16
$11.92
Revenue Growth
N/A
37798.31
52 Week Low
$15.21
$9.12
52 Week High
$29.76
$22.55

Technical Indicators

Market Signals
Indicator
SCVL
KROS
Relative Strength Index (RSI) 51.60 42.24
Support Level $18.40 $18.33
Resistance Level $20.18 $19.94
Average True Range (ATR) 0.76 0.70
MACD 0.00 -0.08
Stochastic Oscillator 48.45 15.21

Price Performance

Historical Comparison
SCVL
KROS

About SCVL Shoe Carnival Inc.

Shoe Carnival Inc is a family footwear retailer that offers a broad assortment of dress, casual, and athletic footwear for men, women, and children with an emphasis on national name brands such as Nike, Skechers, Adidas, Puma, HEYDUDE, Converse, Vans, and Crocs. The company operates its business as one reportable segment based on the similar nature of products sold; merchandising, distribution, and marketing processes involved; target customers; and economic characteristics of stores and e-commerce platforms. Its bricks-first, omnichannel approach provides customers easy access to a wide assortment of branded footwear for work, athletics, daily activities, and special events via a choice of delivery channels.

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Share on Social Networks: